Perhexiline maleate is a small molecule active pharmaceutical ingredient that was first approved in 1974 for cardiovascular applications. It has undergone Phase IV clinical trials and has been withdrawn in at least one region.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 6724-53-4
Lanatoside C
pharmaceutical raw material
D-phenylalanine
pharmaceutical raw material
Drospirenone 6-ene
pharmaceutical raw material
Drospirenone
pharmaceutical raw material
Jantoven
pharmaceutical raw material
(Z)-but-2-enedioic acid;2-(2,2-dicyclohexylethyl)piperidine
JDZOTSLZMQDFLG-BTJKTKAUSA-N
C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3.C(=C\C(=O)O)\C(=O)O